ドネペジルの世界市場レポート 2025年

ドネペジルの市場規模は、今後数年間で安定した成長が見込まれます。2029年には12億7,000万米ドルに成長し、CAGRは4.9%となります。予測期間中に成長が見込まれる背景には、医療費の増加、アルツハイマー病の早期診断の重視、併用療法の需要増加、ヘルスケアインフラへの投資拡大、神経変性疾患に対する意識の高まりなどがあります。主な動向としては、製剤やデリバリー方法の革新、技術の進歩、新規剤形の導入、ジェネリック医薬品の承認、先進研究施設の開発などが挙げられます。

アルツハイマー病の有病率の増加は、ドネペジル市場の成長を促進すると予想されています。アルツハイマー病は進行性の神経疾患で、脳細胞の変性と死滅を引き起こし、記憶喪失、認知機能の低下、行動の変化をもたらします。アルツハイマー病患者の増加は、高齢化、人口増加、ライフスタイル関連のリスク、慢性疾患の増加、遺伝的素因、環境暴露などの要因に起因しています。ドネペジルは、脳内のアセチルコリン濃度に影響を与えることにより、認知機能や日常生活能力を向上させ、アルツハイマー病の症状を管理する上で重要な役割を果たしています。例えば、2024年5月、アルツハイマー病のケア、サポート、研究を専門とする米国の非営利団体であるアルツハイマー病協会の報告によると、アルツハイマー型認知症と診断された65歳以上の米国人の数は、2022年の650万人から2024年には690万人に増加すると推定されています。その結果、アルツハイマー病の罹患率の上昇がドネペジル市場の拡大に拍車をかけています。

ドネペジル市場の主要企業は、患者のコンプライアンスと徐放性製剤による治療効果を高めるため、高度な経皮システムなどの革新的技術の開発に注力しています。ドネペジルシステムとは、主にアルツハイマー病やその他の認知症の治療に使用される薬であるドネペジルの薬理学的作用機序を指します。例えば、2022年10月、米国のバイオ医薬品会社であるコリウム・イノベーション社は、軽度・中等度・重度のアルツハイマー型認知症患者を治療するためのドネペジル経皮吸収型製剤（アドラリティ）を発売しました。この経皮吸収型製剤は、ドネペジルを消化器系をバイパスして皮膚から直接投与するため、消化器系の副作用が軽減され、より簡便な投与方法となります。この技術革新は、治療のアドヒアランスを向上させることにより、アルツハイマー病患者とその介護者の双方に利益をもたらします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ドネペジルPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のドネペジル市場：成長率分析
• 世界のドネペジル市場の実績：規模と成長, 2019-2024
• 世界のドネペジル市場の予測：規模と成長, 2024-2029, 2034F
• 世界ドネペジル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のドネペジル市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 5mg
• 10mg
• 23mg
• 世界のドネペジル市場投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 経皮
• 世界のドネペジル市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 薬局
• 世界のドネペジル市場5mgのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即放性5mg
• 口腔内崩壊錠5mg
• 世界のドネペジル市場10mgのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即放性10mg
• 口腔内崩壊錠10mg
• 世界のドネペジル市場23mgのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐放性23mg
• フィルムコーティング23mg

第7章 地域別・国別分析

• 世界のドネペジル市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のドネペジル市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドネペジル市場：競合情勢
• ドネペジル市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Mylan NV Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sandoz Group AG
• Hetero Drugs Ltd.
• Sun Pharmaceutical Inc.
• Eisai Co. Ltd.
• Cipla Ltd.
• Dr Reddy's Laboratories
• Apotex Inc.
• H Lundbeck A/S
• Zydus Cadila
• Amneal Pharmaceuticals LLC
• Torrent Pharmaceuticals Ltd
• Alkem Laboratories Ltd.
• Jubilant Pharmova Ltd.
• Wockhardt Ltd.
• Luoxin Pharmaceuticals Group

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ドネペジル市場2029：新たな機会を提供する国
• ドネペジル市場2029：新たな機会を提供するセグメント
• ドネペジル市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Donepezil is a medication used to manage symptoms of Alzheimer's disease by preventing the breakdown of acetylcholine, a neurotransmitter essential for memory and cognition. As a cholinesterase inhibitor, it enhances cognitive function and helps slow symptom progression in patients with mild to moderate Alzheimer's disease.

The primary dosage forms of donepezil include 5 mg, 10 mg, and 23 mg. The 5 mg dosage specifically refers to donepezil hydrochloride, commonly prescribed for treating dementia associated with Alzheimer's disease. It is administered through various routes, such as oral and transdermal, and is utilized across multiple settings, including hospitals, clinics, and drugstores.

The donepezil market research report is one of a series of new reports from The Business Research Company that includes donepezil market statistics, including donepezil industry global market size, regional shares, competitors with a donepezil market share, detailed donepezil market segments, market trends and opportunities, and any further data you may need to thrive in the donepezil industry. This donepezil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The donepezil market size has grown strongly in recent years. It will grow from $1.00 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth during the historic period was driven by the increasing prevalence of Alzheimer's disease, a growing geriatric population, rising government spending and support programs, greater awareness of neurodegenerative disorders, and the increasing demand for high-quality nucleic acid samples.

The donepezil market size is expected to see steady growth in the next few years. It will grow to $1.27 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The projected growth during the forecast period is driven by rising healthcare expenditure, a greater emphasis on early diagnosis of Alzheimer's disease, increasing demand for combination therapies, expanding investment in healthcare infrastructure, and growing awareness of neurodegenerative illnesses. Key trends include innovations in drug formulations and delivery methods, technological advancements, the introduction of novel dosage forms, the approval of generic versions of donepezil, and the development of advanced research facilities.

The increasing prevalence of Alzheimer's disease is expected to drive the growth of the donepezil market. Alzheimer's disease is a progressive neurological disorder that leads to brain cell degeneration and death, resulting in memory loss, cognitive decline, and behavioral changes. The rise in Alzheimer's cases is attributed to factors such as an aging population, population growth, lifestyle-related risks, the increase in chronic diseases, genetic predisposition, and environmental exposures. Donepezil plays a crucial role in managing Alzheimer's symptoms by improving cognitive function and daily living abilities through its effect on acetylcholine levels in the brain. For instance, in May 2024, a report by the Alzheimer's Association, a US-based nonprofit dedicated to Alzheimer's care, support, and research, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's disease is fueling the expansion of the donepezil market.

Leading companies in the donepezil market are focusing on developing innovative technologies such as advanced transdermal systems to enhance patient compliance and treatment effectiveness through extended-release formulations. The donepezil system refers to the pharmacological mechanism of action of donepezil, a medication primarily used for treating Alzheimer's disease and other forms of dementia. For instance, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, launched the donepezil transdermal system (Adlarity) for treating patients with mild, moderate, or severe Alzheimer's disease dementia. This transdermal formulation delivers donepezil directly through the skin, bypassing the digestive system, thereby reducing gastrointestinal side effects and offering a more convenient administration method. This innovation benefits both Alzheimer's patients and their caregivers by improving adherence to treatment.

In August 2023, Corium Innovation Inc. partnered with Lotus Pharmaceuticals to expand the availability of ADLARITY(R) in multiple Asian markets. The partnership includes a license agreement for ADLARITY, an innovative donepezil transdermal system for treating Alzheimer's dementia, across ten markets in Asia. Lotus Pharmaceuticals, a Taiwan-based pharmaceutical company, specializes in commercializing both novel and generic pharmaceuticals, helping to bring advanced Alzheimer's treatments to a broader global population.

Major players in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group.

North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in donepezil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the donepezil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The donepezil market consists of sales of orally disintegrating tablets, experimental and niche products, active pharmaceutical ingredients, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Donepezil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on donepezil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for donepezil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The donepezil market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 5mg; 10mg; 23mg
• 2) By Route Of Administration: Oral; Transdermal
• 3) By Application: Hospitals; Clinics; Drugstore
• Subsegments:
• 1) By 5mg: Immediate-Release 5mg; Orally Disintegrating 5mg
• 2) By 10mg: Immediate-Release 10mg; Orally Disintegrating 10mg
• 3) By 23mg: Extended-Release 23mg; Film-Coated 23mg
• Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Teva Pharmaceutical Inc.; Intas Pharmaceuticals Ltd.; Mylan NV
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Donepezil Market Characteristics

3. Donepezil Market Trends And Strategies

4. Donepezil Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Donepezil Growth Analysis And Strategic Analysis Framework

• 5.1. Global Donepezil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Donepezil Market Growth Rate Analysis
• 5.4. Global Donepezil Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Donepezil Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Donepezil Total Addressable Market (TAM)

6. Donepezil Market Segmentation

• 6.1. Global Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5mg
• 10mg
• 23mg
• 6.2. Global Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Transdermal
• 6.3. Global Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Drugstore
• 6.4. Global Donepezil Market, Sub-Segmentation Of 5mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release 5mg
• Orally Disintegrating 5mg
• 6.5. Global Donepezil Market, Sub-Segmentation Of 10mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release 10mg
• Orally Disintegrating 10mg
• 6.6. Global Donepezil Market, Sub-Segmentation Of 23mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release 23mg
• Film-Coated 23mg

7. Donepezil Market Regional And Country Analysis

• 7.1. Global Donepezil Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Donepezil Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Donepezil Market

• 8.1. Asia-Pacific Donepezil Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Donepezil Market

• 9.1. China Donepezil Market Overview
• 9.2. China Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Donepezil Market

• 10.1. India Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Donepezil Market

• 11.1. Japan Donepezil Market Overview
• 11.2. Japan Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Donepezil Market

• 12.1. Australia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Donepezil Market

• 13.1. Indonesia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Donepezil Market

• 14.1. South Korea Donepezil Market Overview
• 14.2. South Korea Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Donepezil Market

• 15.1. Western Europe Donepezil Market Overview
• 15.2. Western Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Donepezil Market

• 16.1. UK Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Donepezil Market

• 17.1. Germany Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Donepezil Market

• 18.1. France Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Donepezil Market

• 19.1. Italy Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Donepezil Market

• 20.1. Spain Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Donepezil Market

• 21.1. Eastern Europe Donepezil Market Overview
• 21.2. Eastern Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Donepezil Market

• 22.1. Russia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Donepezil Market

• 23.1. North America Donepezil Market Overview
• 23.2. North America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Donepezil Market

• 24.1. USA Donepezil Market Overview
• 24.2. USA Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Donepezil Market

• 25.1. Canada Donepezil Market Overview
• 25.2. Canada Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Donepezil Market

• 26.1. South America Donepezil Market Overview
• 26.2. South America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Donepezil Market

• 27.1. Brazil Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Donepezil Market

• 28.1. Middle East Donepezil Market Overview
• 28.2. Middle East Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Donepezil Market

• 29.1. Africa Donepezil Market Overview
• 29.2. Africa Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Donepezil Market Competitive Landscape And Company Profiles

• 30.1. Donepezil Market Competitive Landscape
• 30.2. Donepezil Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Teva Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mylan NV Overview, Products and Services, Strategy and Financial Analysis

31. Donepezil Market Other Major And Innovative Companies

• 31.1. Sandoz Group AG
• 31.2. Hetero Drugs Ltd.
• 31.3. Sun Pharmaceutical Inc.
• 31.4. Eisai Co. Ltd.
• 31.5. Cipla Ltd.
• 31.6. Dr Reddy's Laboratories
• 31.7. Apotex Inc.
• 31.8. H Lundbeck A/S
• 31.9. Zydus Cadila
• 31.10. Amneal Pharmaceuticals LLC
• 31.11. Torrent Pharmaceuticals Ltd
• 31.12. Alkem Laboratories Ltd.
• 31.13. Jubilant Pharmova Ltd.
• 31.14. Wockhardt Ltd.
• 31.15. Luoxin Pharmaceuticals Group

32. Global Donepezil Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Donepezil Market

34. Recent Developments In The Donepezil Market

35. Donepezil Market High Potential Countries, Segments and Strategies

• 35.1 Donepezil Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Donepezil Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Donepezil Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer